BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32845411)

  • 41. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
    Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
    Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist.
    Stull C; Sprow G; Werth VP
    J Rheumatol; 2023 Jan; 50(1):27-35. PubMed ID: 36109075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.
    Wallace DJ; Pistiner M; Nessim S; Metzger AL; Klinenberg JR
    Semin Arthritis Rheum; 1992 Feb; 21(4):221-6. PubMed ID: 1570517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous lupus erythematosus: An update.
    Grönhagen CM; Nyberg F
    Indian Dermatol Online J; 2014 Jan; 5(1):7-13. PubMed ID: 24616847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].
    Kuhn A; Gensch K; Ständer S; Bonsmann G
    Hautarzt; 2006 Mar; 57(3):251-67; quiz 268. PubMed ID: 16501922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of
    Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D
    Front Immunol; 2019; 10():275. PubMed ID: 30846987
    [No Abstract]   [Full Text] [Related]  

  • 50. Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare.
    Braunstein I; Goodman NG; Rosenbach M; Okawa J; Shah A; Krathen M; Kovarik CL; Luning Prak E; Werth VP
    J Am Acad Dermatol; 2012 Apr; 66(4):571-82. PubMed ID: 21821308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of cutaneous manifestations of lupus erythematosus: A systematic review.
    Fairley JL; Oon S; Saracino AM; Nikpour M
    Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies.
    Wenzel J
    Nat Rev Rheumatol; 2019 Sep; 15(9):519-532. PubMed ID: 31399711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians.
    Chanprapaph K; Tankunakorn J; Suchonwanit P; Rutnin S
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):131-147. PubMed ID: 33280074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
    Vale ECSD; Garcia LC
    An Bras Dermatol; 2023; 98(3):355-372. PubMed ID: 36868923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review.
    Chasset F; Francès C
    Drugs; 2019 Jul; 79(11):1199-1215. PubMed ID: 31228033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of cutaneous lupus erythematosus.
    Kuhn A; Ochsendorf F; Bonsmann G
    Lupus; 2010 Aug; 19(9):1125-36. PubMed ID: 20693207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Periorbital erythema and swelling as a presenting sign of lupus erythematosus in tertiary referral centers and literature review.
    Wu MY; Wang CH; Ng CY; Kuo TT; Chang YC; Yang CH; Lin JY; Ho HC; Chung WH; Chen CB
    Lupus; 2018 Oct; 27(11):1828-1837. PubMed ID: 30134759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea.
    Oh EH; Kim EJ; Ro YS; Ko JY
    J Dermatol; 2018 Apr; 45(4):436-443. PubMed ID: 29423919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photosensitivity in cutaneous lupus erythematosus.
    Kim A; Chong BF
    Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):4-11. PubMed ID: 23281691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.